DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System
Effective multi-agent/multivalent vaccines that confer protection against more than one disease are highly desirable to the patient and to health-care professionals. Electroporation of DNA vaccines, whereby tissues injected with DNA are subjected to localized electrical currents, is an ideal platform technology that achieves protective immune responses to multivalent vaccination. Here, we describe an electroporation-based immunization technique capable of administering a cocktail of DNA vaccinations in vivo. Immune response measurements, including protection from pathogen challenge and induction of antigen-specific antibody responses and cell-mediated immune responses, are also discussed.
Key wordsAnthrax Plague DNA vaccine Recombinant protein vaccine Intramuscular introduction
- 1.CDC (2000) Use of anthrax vaccine in the united states: recommendations of the advisory committee on immunization practices. MMWR 49:1–22Google Scholar
- 6.Robinson HL, Ginsberg HS, Davis HL, Johnston SA, Liu MA (1997) The scientific future of DNA for immunization. Am Acad MicrobiolGoogle Scholar
- 11.Dupuy LC, Richards MJ, Ellefsen B et al (2011) A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clin Vaccine Immunol 18:707–716PubMedCentralPubMedCrossRefGoogle Scholar
- 21.Albrecht MT, Li H, Williamson ED et al (2007) Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect Immun 75:5425–5433PubMedCentralPubMedCrossRefGoogle Scholar